These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21703195)

  • 41. Nutrition therapy for liver diseases based on the status of nutritional intake.
    Yasutake K; Kohjima M; Nakashima M; Kotoh K; Nakamuta M; Enjoji M
    Gastroenterol Res Pract; 2012; 2012():859697. PubMed ID: 23197979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update in infectious diseases.
    Arama V; Olaru ID
    Maedica (Bucur); 2011 Oct; 6(4):337-8. PubMed ID: 22879851
    [No Abstract]   [Full Text] [Related]  

  • 43. Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.
    Enjoji M; Kohjima M; Kotoh K; Nakamuta M
    Int J Hepatol; 2012; 2012():264017. PubMed ID: 22701799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.
    Butt AA; Umbleja T; Andersen JW; Sherman KE; Chung RT;
    Clin Infect Dis; 2012 Sep; 55(5):631-8. PubMed ID: 22563020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis.
    Cammà C; Cabibbo G; Bronte F; Enea M; Licata A; Attanasio M; Andriulli A; Craxì A
    J Hepatol; 2009 Oct; 51(4):675-81. PubMed ID: 19665247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-analysis: insulin resistance and sustained virological response in hepatitis C.
    Eslam M; Aparcero R; Kawaguchi T; Del Campo JA; Sata M; Khattab MA; Romero-Gomez M
    Aliment Pharmacol Ther; 2011 Aug; 34(3):297-305. PubMed ID: 21623851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma IL-6 and IL-9 predict the failure of interferon-α plus ribavirin therapy in HIV/HCV-coinfected patients.
    Guzmán-Fulgencio M; Jiménez JL; Berenguer J; Fernández-Rodríguez A; López JC; Cosín J; Miralles P; Micheloud D; Muñoz-Fernández MÁ; Resino S
    J Antimicrob Chemother; 2012 May; 67(5):1238-45. PubMed ID: 22294644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance.
    Chan CH; Hansen RD; Gilliver RS; Jones BE
    Intern Med J; 2013 Jun; 43(6):656-62. PubMed ID: 23506416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.
    Abd El-Wahab EW; Mikheal A; Sidkey F; Shatat HZ
    J Med Virol; 2015 Mar; 87(3):428-40. PubMed ID: 25583244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
    Deltenre P; Louvet A; Lemoine M; Mourad A; Fartoux L; Moreno C; Henrion J; Mathurin P; Serfaty L
    J Hepatol; 2011 Dec; 55(6):1187-94. PubMed ID: 21703195
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.